2.16.840.1.113883.5.145/static-2012-07-24: Unterschied zwischen den Versionen
ADbot (Diskussion | Beiträge) (Automated TermBot page content) |
ADbot (Diskussion | Beiträge) (Automated TermBot page content) |
||
Zeile 9: | Zeile 9: | ||
| colspan=2 bgcolor="#F6F3EE"|''VaccineType'' | | colspan=2 bgcolor="#F6F3EE"|''VaccineType'' | ||
| bgcolor="#F6F3EE"|2.16.840.1.113883.5.145 | | bgcolor="#F6F3EE"|2.16.840.1.113883.5.145 | ||
− | | bgcolor="#F6F3EE"|2012-07- | + | | bgcolor="#F6F3EE"|2012-07-24 |
| bgcolor="#F6F3EE"|definitiv | | bgcolor="#F6F3EE"|definitiv | ||
|- | |- | ||
Zeile 17: | Zeile 17: | ||
| bgcolor="#ECE9E4" colspan="2"|'''Beschreibung''' | | bgcolor="#ECE9E4" colspan="2"|'''Beschreibung''' | ||
|- | |- | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''54''' | ||
+ | |<font color="grey">(en-US)</font> adenovirus, type 4 | ||
+ | | colspan="2" |<p>adenovirus vaccine, type 4, live, oral</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''55''' | ||
+ | |<font color="grey">(en-US)</font> adenovirus, type 7 | ||
+ | | colspan="2" |<p>adenovirus vaccine, type 7, live, oral</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''82''' | ||
+ | |<font color="grey">(en-US)</font> adenovirus, NOS | ||
+ | | colspan="2" |<p>adenovirus vaccine, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''24''' | ||
+ | |<font color="grey">(en-US)</font> Anthrax | ||
+ | | colspan="2" |<p>anthrax vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''19''' | ||
+ | |<font color="grey">(en-US)</font> BCG | ||
+ | | colspan="2" |<p>Bacillus Calmette-Guerin vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''27''' | ||
+ | |<font color="grey">(en-US)</font> botulinum antitoxin | ||
+ | | colspan="2" |<p>botulinum antitoxin</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''26''' | ||
+ | |<font color="grey">(en-US)</font> Cholera | ||
+ | | colspan="2" |<p>cholera vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''29''' | ||
+ | |<font color="grey">(en-US)</font> CMVIG | ||
+ | | colspan="2" |<p>cytomegalovirus immune globulin, intravenous</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''56''' | ||
+ | |<font color="grey">(en-US)</font> dengue fever | ||
+ | | colspan="2" |<p>dengue fever vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''12''' | ||
+ | |<font color="grey">(en-US)</font> diphtheria antitoxin | ||
+ | | colspan="2" |<p>diphtheria antitoxin</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''28''' | ||
+ | |<font color="grey">(en-US)</font> DT (pediatric) | ||
+ | | colspan="2" |<p>diphtheria and tetanus toxoids, adsorbed for pediatric use</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''20''' | ||
+ | |<font color="grey">(en-US)</font> DTaP | ||
+ | | colspan="2" |<p>diphtheria, tetanus toxoids and acellular pertussis vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''50''' | ||
+ | |<font color="grey">(en-US)</font> DTaPHib | ||
+ | | colspan="2" |<p>DTaP-Haemophilus influenzae type b conjugate vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''1''' | ||
+ | |<font color="grey">(en-US)</font> DTP | ||
+ | | colspan="2" |<p>diphtheria, tetanus toxoids and pertussis vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''22''' | ||
+ | |<font color="grey">(en-US)</font> DTP-Hib | ||
+ | | colspan="2" |<p>DTP-Haemophilus influenzae type b conjugate vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''57''' | ||
+ | |<font color="grey">(en-US)</font> Hantavirus | ||
+ | | colspan="2" |<p>hantavirus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''52''' | ||
+ | |<font color="grey">(en-US)</font> Hep A, adult | ||
+ | | colspan="2" |<p>hepatitis A vaccine, adult dosage</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''83''' | ||
+ | |<font color="grey">(en-US)</font> Hep A, ped/adol, 2 dose | ||
+ | | colspan="2" |<p>hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''84''' | ||
+ | |<font color="grey">(en-US)</font> Hep A, ped/adol, 3 dose | ||
+ | | colspan="2" |<p>hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''31''' | ||
+ | |<font color="grey">(en-US)</font> Hep A, pediatric, NOS | ||
+ | | colspan="2" |<p>hepatitis A vaccine, pediatric dosage, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''85''' | ||
+ | |<font color="grey">(en-US)</font> Hep A, NOS | ||
+ | | colspan="2" |<p>hepatitis A vaccine, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''30''' | ||
+ | |<font color="grey">(en-US)</font> HBIG | ||
+ | | colspan="2" |<p>hepatitis B immune globulin</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''8''' | ||
+ | |<font color="grey">(en-US)</font> Hep B, adolescent or pediatric | ||
+ | | colspan="2" |<p>hepatitis B vaccine, pediatric or pediatric/adolescent dosage</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''42''' | ||
+ | |<font color="grey">(en-US)</font> Hep B, adolescent/high risk infant | ||
+ | | colspan="2" |<p>hepatitis B vaccine, adolescent/high risk infant dosage</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''43''' | ||
+ | |<font color="grey">(en-US)</font> Hep B, adult | ||
+ | | colspan="2" |<p>hepatitis B vaccine, adult dosage</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''44''' | ||
+ | |<font color="grey">(en-US)</font> Hep B, dialysis | ||
+ | | colspan="2" |<p>hepatitis B vaccine, dialysis patient dosage</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''45''' | ||
+ | |<font color="grey">(en-US)</font> Hep B, NOS | ||
+ | | colspan="2" |<p>hepatitis B vaccine, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''58''' | ||
+ | |<font color="grey">(en-US)</font> Hep C | ||
+ | | colspan="2" |<p>hepatitis C vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''59''' | ||
+ | |<font color="grey">(en-US)</font> Hep E | ||
+ | | colspan="2" |<p>hepatitis E vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''60''' | ||
+ | |<font color="grey">(en-US)</font> herpes simplex 2 | ||
+ | | colspan="2" |<p>herpes simplex virus, type 2 vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''46''' | ||
+ | |<font color="grey">(en-US)</font> Hib (PRP-D) | ||
+ | | colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-D conjugate</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''47''' | ||
+ | |<font color="grey">(en-US)</font> Hib (HbOC) | ||
+ | | colspan="2" |<p>Haemophilus influenzae type b vaccine, HbOC conjugate</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''48''' | ||
+ | |<font color="grey">(en-US)</font> Hib (PRP-T) | ||
+ | | colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-T conjugate</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''49''' | ||
+ | |<font color="grey">(en-US)</font> Hib (PRP-OMP) | ||
+ | | colspan="2" |<p>Haemophilus influenzae type b vaccine, PRP-OMP conjugate</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''17''' | ||
+ | |<font color="grey">(en-US)</font> Hib, NOS | ||
+ | | colspan="2" |<p>Haemophilus influenzae type b vaccine, conjugate NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''51''' | ||
+ | |<font color="grey">(en-US)</font> Hib-Hep B | ||
+ | | colspan="2" |<p>Haemophilus influenzae type b conjugate and Hepatitis B vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''61''' | ||
+ | |<font color="grey">(en-US)</font> HIV | ||
+ | | colspan="2" |<p>human immunodeficiency virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''62''' | ||
+ | |<font color="grey">(en-US)</font> HPV | ||
+ | | colspan="2" |<p>human papilloma virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''86''' | ||
+ | |<font color="grey">(en-US)</font> IG | ||
+ | | colspan="2" |<p>immune globulin, intramuscular</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''87''' | ||
+ | |<font color="grey">(en-US)</font> IGIV | ||
+ | | colspan="2" |<p>immune globulin, intravenous</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''14''' | ||
+ | |<font color="grey">(en-US)</font> IG, NOS | ||
+ | | colspan="2" |<p>immune globulin, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''15''' | ||
+ | |<font color="grey">(en-US)</font> influenza, split (incl. purified surface antigen) | ||
+ | | colspan="2" |<p>influenza virus vaccine, split virus (incl. purified surface antigen)</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''16''' | ||
+ | |<font color="grey">(en-US)</font> influenza, whole | ||
+ | | colspan="2" |<p>influenza virus vaccine, whole virus</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''88''' | ||
+ | |<font color="grey">(en-US)</font> influenza, NOS | ||
+ | | colspan="2" |<p>influenza virus vaccine, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''10''' | ||
+ | |<font color="grey">(en-US)</font> IPV | ||
+ | | colspan="2" |<p>poliovirus vaccine, inactivated</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''2''' | ||
+ | |<font color="grey">(en-US)</font> OPV | ||
+ | | colspan="2" |<p>poliovirus vaccine, live, oral</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''89''' | ||
+ | |<font color="grey">(en-US)</font> polio, NOS | ||
+ | | colspan="2" |<p>poliovirus vaccine, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''39''' | ||
+ | |<font color="grey">(en-US)</font> Japanese encephalitis | ||
+ | | colspan="2" |<p>Japanese encephalitis vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''63''' | ||
+ | |<font color="grey">(en-US)</font> Junin virus | ||
+ | | colspan="2" |<p>Junin virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''64''' | ||
+ | |<font color="grey">(en-US)</font> leishmaniasis | ||
+ | | colspan="2" |<p>leishmaniasis vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''65''' | ||
+ | |<font color="grey">(en-US)</font> leprosy | ||
+ | | colspan="2" |<p>leprosy vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''66''' | ||
+ | |<font color="grey">(en-US)</font> Lyme disease | ||
+ | | colspan="2" |<p>Lyme disease vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''3''' | ||
+ | |<font color="grey">(en-US)</font> MMR | ||
+ | | colspan="2" |<p>measles, mumps and rubella virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''4''' | ||
+ | |<font color="grey">(en-US)</font> M/R | ||
+ | | colspan="2" |<p>measles and rubella virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''94''' | ||
+ | |<font color="grey">(en-US)</font> MMRV | ||
+ | | colspan="2" |<p>measles, mumps, rubella, and varicella virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''67''' | ||
+ | |<font color="grey">(en-US)</font> malaria | ||
+ | | colspan="2" |<p>malaria vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''5''' | ||
+ | |<font color="grey">(en-US)</font> measles | ||
+ | | colspan="2" |<p>measles virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''68''' | ||
+ | |<font color="grey">(en-US)</font> melanoma | ||
+ | | colspan="2" |<p>melanoma vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''32''' | ||
+ | |<font color="grey">(en-US)</font> meningococcal | ||
+ | | colspan="2" |<p>meningococcal polysaccharide vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''7''' | ||
+ | |<font color="grey">(en-US)</font> mumps | ||
+ | | colspan="2" |<p>mumps virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''69''' | ||
+ | |<font color="grey">(en-US)</font> parainfluenza-3 | ||
+ | | colspan="2" |<p>parainfluenza-3 virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''11''' | ||
+ | |<font color="grey">(en-US)</font> pertussis | ||
+ | | colspan="2" |<p>pertussis vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''23''' | ||
+ | |<font color="grey">(en-US)</font> plague | ||
+ | | colspan="2" |<p>plague vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''33''' | ||
+ | |<font color="grey">(en-US)</font> pneumococcal | ||
+ | | colspan="2" |<p>pneumococcal polysaccharide vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''100''' | ||
+ | |<font color="grey">(en-US)</font> pneumococcal conjugate | ||
+ | | colspan="2" |<p>pneumococcal conjugate vaccine, polyvalent</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''70''' | ||
+ | |<font color="grey">(en-US)</font> Q fever | ||
+ | | colspan="2" |<p>Q fever vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''18''' | ||
+ | |<font color="grey">(en-US)</font> rabies, intramuscular injection | ||
+ | | colspan="2" |<p>rabies vaccine, for intramuscular injection</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''40''' | ||
+ | |<font color="grey">(en-US)</font> rabies, intradermal injection | ||
+ | | colspan="2" |<p>rabies vaccine, for intradermal injection</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''90''' | ||
+ | |<font color="grey">(en-US)</font> rabies, NOS | ||
+ | | colspan="2" |<p>rabies vaccine, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''72''' | ||
+ | |<font color="grey">(en-US)</font> rheumatic fever | ||
+ | | colspan="2" |<p>rheumatic fever vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''73''' | ||
+ | |<font color="grey">(en-US)</font> Rift Valley fever | ||
+ | | colspan="2" |<p>Rift Valley fever vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''34''' | ||
+ | |<font color="grey">(en-US)</font> RIG | ||
+ | | colspan="2" |<p>rabies immune globulin</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''74''' | ||
+ | |<font color="grey">(en-US)</font> rotavirus | ||
+ | | colspan="2" |<p>rotavirus vaccine, tetravalent, live, oral</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''71''' | ||
+ | |<font color="grey">(en-US)</font> RSV-IGIV | ||
+ | | colspan="2" |<p>respiratory syncytial virus immune globulin, intravenous</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''93''' | ||
+ | |<font color="grey">(en-US)</font> RSV-Mab | ||
+ | | colspan="2" |<p>respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''6''' | ||
+ | |<font color="grey">(en-US)</font> rubella | ||
+ | | colspan="2" |<p>rubella virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''38''' | ||
+ | |<font color="grey">(en-US)</font> rubella/mumps | ||
+ | | colspan="2" |<p>rubella and mumps virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''75''' | ||
+ | |<font color="grey">(en-US)</font> smallpox | ||
+ | | colspan="2" |<p>smallpox vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''76''' | ||
+ | |<font color="grey">(en-US)</font> Staphylococcus bacterio lysate | ||
+ | | colspan="2" |<p>Staphylococcus bacteriophage lysate</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''9''' | ||
+ | |<font color="grey">(en-US)</font> Td (adult) | ||
+ | | colspan="2" |<p>tetanus and diphtheria toxoids, adsorbed for adult use</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''35''' | ||
+ | |<font color="grey">(en-US)</font> tetanus toxoid | ||
+ | | colspan="2" |<p>tetanus toxoid</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''77''' | ||
+ | |<font color="grey">(en-US)</font> tick-borne encephalitis | ||
+ | | colspan="2" |<p>tick-borne encephalitis vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''13''' | ||
+ | |<font color="grey">(en-US)</font> TIG | ||
+ | | colspan="2" |<p>tetanus immune globulin</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''95''' | ||
+ | |<font color="grey">(en-US)</font> TST-OT tine test | ||
+ | | colspan="2" |<p>tuberculin skin test; old tuberculin, multipuncture device</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''96''' | ||
+ | |<font color="grey">(en-US)</font> TST-PPD intradermal | ||
+ | | colspan="2" |<p>tuberculin skin test; purified protein derivative solution, intradermal</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''97''' | ||
+ | |<font color="grey">(en-US)</font> TST-PPD tine test | ||
+ | | colspan="2" |<p>tuberculin skin test; purified protein derivative, multipuncture device</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''98''' | ||
+ | |<font color="grey">(en-US)</font> TST, NOS | ||
+ | | colspan="2" |<p>tuberculin skin test; NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''78''' | ||
+ | |<font color="grey">(en-US)</font> tularemia vaccine | ||
+ | | colspan="2" |<p>tularemia vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''25''' | ||
+ | |<font color="grey">(en-US)</font> typhoid, oral | ||
+ | | colspan="2" |<p>typhoid vaccine, live, oral</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''41''' | ||
+ | |<font color="grey">(en-US)</font> typhoid, parenteral | ||
+ | | colspan="2" |<p>typhoid vaccine, parenteral, other than acetone-killed, dried</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''53''' | ||
+ | |<font color="grey">(en-US)</font> typhoid, parenteral, AKD (U.S. military) | ||
+ | | colspan="2" |<p>typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''101''' | ||
+ | |<font color="grey">(en-US)</font> typhoid, ViCPs | ||
+ | | colspan="2" |<p>Typhoid Vi capsular polysaccharide vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''91''' | ||
+ | |<font color="grey">(en-US)</font> typhoid, NOS | ||
+ | | colspan="2" |<p>typhoid vaccine, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''79''' | ||
+ | |<font color="grey">(en-US)</font> vaccinia immune globulin | ||
+ | | colspan="2" |<p>vaccinia immune globulin</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''21''' | ||
+ | |<font color="grey">(en-US)</font> varicella | ||
+ | | colspan="2" |<p>varicella virus vaccine</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''81''' | ||
+ | |<font color="grey">(en-US)</font> VEE, inactivated | ||
+ | | colspan="2" |<p>Venezuelan equine encephalitis, inactivated</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''80''' | ||
+ | |<font color="grey">(en-US)</font> VEE, live | ||
+ | | colspan="2" |<p>Venezuelan equine encephalitis, live, attenuated</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''92''' | ||
+ | |<font color="grey">(en-US)</font> VEE, NOS | ||
+ | | colspan="2" |<p>Venezuelan equine encephalitis vaccine, NOS</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''36''' | ||
+ | |<font color="grey">(en-US)</font> VZIG | ||
+ | | colspan="2" |<p>varicella zoster immune globulin</p> | ||
+ | |- | ||
+ | |0-L | ||
+ | |'''37''' | ||
+ | |<font color="grey">(en-US)</font> yellow fever | ||
+ | | colspan="2" |<p>yellow fever vaccine</p> | ||
|} | |} |
Version vom 11. November 2012, 18:50 Uhr
Codesystem Name | Codesystem Id | Version / Eingangsdatum | Status | |
---|---|---|---|---|
VaccineType | 2.16.840.1.113883.5.145 | 2012-07-24 | definitiv | |
Level/Typ | Code | Anzeigename | Beschreibung | |
0-L | 54 | (en-US) adenovirus, type 4 | adenovirus vaccine, type 4, live, oral | |
0-L | 55 | (en-US) adenovirus, type 7 | adenovirus vaccine, type 7, live, oral | |
0-L | 82 | (en-US) adenovirus, NOS | adenovirus vaccine, NOS | |
0-L | 24 | (en-US) Anthrax | anthrax vaccine | |
0-L | 19 | (en-US) BCG | Bacillus Calmette-Guerin vaccine | |
0-L | 27 | (en-US) botulinum antitoxin | botulinum antitoxin | |
0-L | 26 | (en-US) Cholera | cholera vaccine | |
0-L | 29 | (en-US) CMVIG | cytomegalovirus immune globulin, intravenous | |
0-L | 56 | (en-US) dengue fever | dengue fever vaccine | |
0-L | 12 | (en-US) diphtheria antitoxin | diphtheria antitoxin | |
0-L | 28 | (en-US) DT (pediatric) | diphtheria and tetanus toxoids, adsorbed for pediatric use | |
0-L | 20 | (en-US) DTaP | diphtheria, tetanus toxoids and acellular pertussis vaccine | |
0-L | 50 | (en-US) DTaPHib | DTaP-Haemophilus influenzae type b conjugate vaccine | |
0-L | 1 | (en-US) DTP | diphtheria, tetanus toxoids and pertussis vaccine | |
0-L | 22 | (en-US) DTP-Hib | DTP-Haemophilus influenzae type b conjugate vaccine | |
0-L | 57 | (en-US) Hantavirus | hantavirus vaccine | |
0-L | 52 | (en-US) Hep A, adult | hepatitis A vaccine, adult dosage | |
0-L | 83 | (en-US) Hep A, ped/adol, 2 dose | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | |
0-L | 84 | (en-US) Hep A, ped/adol, 3 dose | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | |
0-L | 31 | (en-US) Hep A, pediatric, NOS | hepatitis A vaccine, pediatric dosage, NOS | |
0-L | 85 | (en-US) Hep A, NOS | hepatitis A vaccine, NOS | |
0-L | 30 | (en-US) HBIG | hepatitis B immune globulin | |
0-L | 8 | (en-US) Hep B, adolescent or pediatric | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | |
0-L | 42 | (en-US) Hep B, adolescent/high risk infant | hepatitis B vaccine, adolescent/high risk infant dosage | |
0-L | 43 | (en-US) Hep B, adult | hepatitis B vaccine, adult dosage | |
0-L | 44 | (en-US) Hep B, dialysis | hepatitis B vaccine, dialysis patient dosage | |
0-L | 45 | (en-US) Hep B, NOS | hepatitis B vaccine, NOS | |
0-L | 58 | (en-US) Hep C | hepatitis C vaccine | |
0-L | 59 | (en-US) Hep E | hepatitis E vaccine | |
0-L | 60 | (en-US) herpes simplex 2 | herpes simplex virus, type 2 vaccine | |
0-L | 46 | (en-US) Hib (PRP-D) | Haemophilus influenzae type b vaccine, PRP-D conjugate | |
0-L | 47 | (en-US) Hib (HbOC) | Haemophilus influenzae type b vaccine, HbOC conjugate | |
0-L | 48 | (en-US) Hib (PRP-T) | Haemophilus influenzae type b vaccine, PRP-T conjugate | |
0-L | 49 | (en-US) Hib (PRP-OMP) | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | |
0-L | 17 | (en-US) Hib, NOS | Haemophilus influenzae type b vaccine, conjugate NOS | |
0-L | 51 | (en-US) Hib-Hep B | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | |
0-L | 61 | (en-US) HIV | human immunodeficiency virus vaccine | |
0-L | 62 | (en-US) HPV | human papilloma virus vaccine | |
0-L | 86 | (en-US) IG | immune globulin, intramuscular | |
0-L | 87 | (en-US) IGIV | immune globulin, intravenous | |
0-L | 14 | (en-US) IG, NOS | immune globulin, NOS | |
0-L | 15 | (en-US) influenza, split (incl. purified surface antigen) | influenza virus vaccine, split virus (incl. purified surface antigen) | |
0-L | 16 | (en-US) influenza, whole | influenza virus vaccine, whole virus | |
0-L | 88 | (en-US) influenza, NOS | influenza virus vaccine, NOS | |
0-L | 10 | (en-US) IPV | poliovirus vaccine, inactivated | |
0-L | 2 | (en-US) OPV | poliovirus vaccine, live, oral | |
0-L | 89 | (en-US) polio, NOS | poliovirus vaccine, NOS | |
0-L | 39 | (en-US) Japanese encephalitis | Japanese encephalitis vaccine | |
0-L | 63 | (en-US) Junin virus | Junin virus vaccine | |
0-L | 64 | (en-US) leishmaniasis | leishmaniasis vaccine | |
0-L | 65 | (en-US) leprosy | leprosy vaccine | |
0-L | 66 | (en-US) Lyme disease | Lyme disease vaccine | |
0-L | 3 | (en-US) MMR | measles, mumps and rubella virus vaccine | |
0-L | 4 | (en-US) M/R | measles and rubella virus vaccine | |
0-L | 94 | (en-US) MMRV | measles, mumps, rubella, and varicella virus vaccine | |
0-L | 67 | (en-US) malaria | malaria vaccine | |
0-L | 5 | (en-US) measles | measles virus vaccine | |
0-L | 68 | (en-US) melanoma | melanoma vaccine | |
0-L | 32 | (en-US) meningococcal | meningococcal polysaccharide vaccine | |
0-L | 7 | (en-US) mumps | mumps virus vaccine | |
0-L | 69 | (en-US) parainfluenza-3 | parainfluenza-3 virus vaccine | |
0-L | 11 | (en-US) pertussis | pertussis vaccine | |
0-L | 23 | (en-US) plague | plague vaccine | |
0-L | 33 | (en-US) pneumococcal | pneumococcal polysaccharide vaccine | |
0-L | 100 | (en-US) pneumococcal conjugate | pneumococcal conjugate vaccine, polyvalent | |
0-L | 70 | (en-US) Q fever | Q fever vaccine | |
0-L | 18 | (en-US) rabies, intramuscular injection | rabies vaccine, for intramuscular injection | |
0-L | 40 | (en-US) rabies, intradermal injection | rabies vaccine, for intradermal injection | |
0-L | 90 | (en-US) rabies, NOS | rabies vaccine, NOS | |
0-L | 72 | (en-US) rheumatic fever | rheumatic fever vaccine | |
0-L | 73 | (en-US) Rift Valley fever | Rift Valley fever vaccine | |
0-L | 34 | (en-US) RIG | rabies immune globulin | |
0-L | 74 | (en-US) rotavirus | rotavirus vaccine, tetravalent, live, oral | |
0-L | 71 | (en-US) RSV-IGIV | respiratory syncytial virus immune globulin, intravenous | |
0-L | 93 | (en-US) RSV-Mab | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | |
0-L | 6 | (en-US) rubella | rubella virus vaccine | |
0-L | 38 | (en-US) rubella/mumps | rubella and mumps virus vaccine | |
0-L | 75 | (en-US) smallpox | smallpox vaccine | |
0-L | 76 | (en-US) Staphylococcus bacterio lysate | Staphylococcus bacteriophage lysate | |
0-L | 9 | (en-US) Td (adult) | tetanus and diphtheria toxoids, adsorbed for adult use | |
0-L | 35 | (en-US) tetanus toxoid | tetanus toxoid | |
0-L | 77 | (en-US) tick-borne encephalitis | tick-borne encephalitis vaccine | |
0-L | 13 | (en-US) TIG | tetanus immune globulin | |
0-L | 95 | (en-US) TST-OT tine test | tuberculin skin test; old tuberculin, multipuncture device | |
0-L | 96 | (en-US) TST-PPD intradermal | tuberculin skin test; purified protein derivative solution, intradermal | |
0-L | 97 | (en-US) TST-PPD tine test | tuberculin skin test; purified protein derivative, multipuncture device | |
0-L | 98 | (en-US) TST, NOS | tuberculin skin test; NOS | |
0-L | 78 | (en-US) tularemia vaccine | tularemia vaccine | |
0-L | 25 | (en-US) typhoid, oral | typhoid vaccine, live, oral | |
0-L | 41 | (en-US) typhoid, parenteral | typhoid vaccine, parenteral, other than acetone-killed, dried | |
0-L | 53 | (en-US) typhoid, parenteral, AKD (U.S. military) | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | |
0-L | 101 | (en-US) typhoid, ViCPs | Typhoid Vi capsular polysaccharide vaccine | |
0-L | 91 | (en-US) typhoid, NOS | typhoid vaccine, NOS | |
0-L | 79 | (en-US) vaccinia immune globulin | vaccinia immune globulin | |
0-L | 21 | (en-US) varicella | varicella virus vaccine | |
0-L | 81 | (en-US) VEE, inactivated | Venezuelan equine encephalitis, inactivated | |
0-L | 80 | (en-US) VEE, live | Venezuelan equine encephalitis, live, attenuated | |
0-L | 92 | (en-US) VEE, NOS | Venezuelan equine encephalitis vaccine, NOS | |
0-L | 36 | (en-US) VZIG | varicella zoster immune globulin | |
0-L | 37 | (en-US) yellow fever | yellow fever vaccine |